Your browser doesn't support javascript.
loading
2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.
Levine, Glenn N; Bates, Eric R; Blankenship, James C; Bailey, Steven R; Bittl, John A; Cercek, Bojan; Chambers, Charles E; Ellis, Stephen G; Guyton, Robert A; Hollenberg, Steven M; Khot, Umesh N; Lange, Richard A; Mauri, Laura; Mehran, Roxana; Moussa, Issam D; Mukherjee, Debabrata; Ting, Henry H; O'Gara, Patrick T; Kushner, Frederick G; Ascheim, Deborah D; Brindis, Ralph G; Casey, Donald E; Chung, Mina K; de Lemos, James A; Diercks, Deborah B; Fang, James C; Franklin, Barry A; Granger, Christopher B; Krumholz, Harlan M; Linderbaum, Jane A; Morrow, David A; Kristin Newby, L; Ornato, Joseph P; Ou, Narith; Radford, Martha J; Tamis-Holland, Jacqueline E; Tommaso, Carl L; Tracy, Cynthia M; Joseph Woo, Y; Zhao, David X; Halperin, Jonathan L; Levine, Glenn N; Anderson, Jeffrey L; Albert, Nancy M; Al-Khatib, Sana M; Birtcher, Kim K; Bozkurt, Biykem; Brindis, Ralph G; Cigarroa, Joaquin E; Curtis, Lesley H.
Afiliação
  • Levine GN; ACC/AHA Representative.
  • Bates ER; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Blankenship JC; ACC/AHA Representative.
  • Bailey SR; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Bittl JA; SCAI Representative.
  • Cercek B; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Chambers CE; SCAI Representative.
  • Ellis SG; ACC/AHA Representative.
  • Guyton RA; ACC/AHA Representative.
  • Hollenberg SM; SCAI Representative.
  • Khot UN; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Lange RA; ACC/AHA Representative.
  • Mauri L; ACC/AHA Task Force on Clinical Practice Guidelines Liaison.
  • Mehran R; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Moussa ID; ACC/AHA Representative.
  • Mukherjee D; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Ting HH; ACC/AHA Representative.
  • O'Gara PT; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Kushner FG; ACC/AHA Representative.
  • Ascheim DD; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Brindis RG; SCAI Representative.
  • Casey DE; SCAI Representative.
  • Chung MK; ACC/AHA Representative.
  • de Lemos JA; ACC/AHA Representative.
  • Fang JC; ACC/AHA Representative.
  • Franklin BA; ACC/AHA Representative.
  • Granger CB; Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 2015, after the writing effort was completed. In accordance with ACC/AHA policy, she recused herself from the final voting process.
  • Krumholz HM; ACC/AHA Task Force on Clinical Practice Guidelines Liaison.
  • Linderbaum JA; ACP Representative.
  • Morrow DA; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Kristin Newby L; ACC/AHA Representative.
  • Ornato JP; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Ou N; ACC/AHA Representative.
  • Radford MJ; ACEP Representative.
  • Tamis-Holland JE; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Tommaso CL; ACC/AHA Representative.
  • Tracy CM; ACC/AHA Representative.
  • Joseph Woo Y; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Zhao DX; ACC/AHA Representative.
  • Halperin JL; ACC/AHA Representative.
  • Levine GN; ACC/AHA Representative.
  • Anderson JL; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Albert NM; ACC/AHA Representative.
  • Al-Khatib SM; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Birtcher KK; ACC/AHA Representative.
  • Bozkurt B; Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information.
  • Brindis RG; ACC/AHA Representative.
  • Cigarroa JE; ACC/AHA Representative.
  • Curtis LH; ACC/AHA Representative.
Catheter Cardiovasc Interv ; 87(6): 1001-19, 2016 May.
Article em En | MEDLINE | ID: mdl-26489034
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sociedades Médicas / Cardiologia / Angiografia Coronária / Intervenção Coronária Percutânea / Infarto do Miocárdio com Supradesnível do Segmento ST / American Heart Association Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Catheter Cardiovasc Interv Assunto da revista: CARDIOLOGIA Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sociedades Médicas / Cardiologia / Angiografia Coronária / Intervenção Coronária Percutânea / Infarto do Miocárdio com Supradesnível do Segmento ST / American Heart Association Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Catheter Cardiovasc Interv Assunto da revista: CARDIOLOGIA Ano de publicação: 2016 Tipo de documento: Article